Prof. Dr. Mesut Seker

Prof. Dr. Mesut Seker is a senior Medical Oncology specialist with a strong academic and clinical background in the treatment of solid tumors and systemic cancer care. He completed his medical degree at Cukurova University, followed by advanced training in Internal Medicine and then Medical Oncology at Dr. Lutfi Kırdar Kartal Training and Research Hospital in Istanbul. His career includes specialist, associate professor, and professor-level appointments at major Turkish institutions including Tekirdag State Hospital, Dr. Lutfi Kirdar Kartal Training and Research Hospital, Medipol University, and Bezmialem Vakif University. He is currently associated with Medipol Mega University Hospital and is also listed in Medipol University’s academic faculty pages.

His professional profile reflects broad expertise in adult cancer care, especially in the evaluation, staging, treatment planning, and long-term management of patients who need modern oncology services. While his Medipol page does not publish a formal awards or society-membership list, it does show a substantial record of peer-reviewed scientific publications, indicating strong academic involvement alongside patient care. His published work includes research in gastric cancer, colorectal cancer, lymphoma, breast malignancies, ovarian cancer, gastrointestinal stromal tumors, treatment response, and prognostic factors in cancer. PubMed-indexed studies linked to his name further support his active contribution to oncology literature.

• MD – Cukurova University, Faculty of Medicine (1996)
• Residency / Specialization in Internal Medicine – Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul (2003)
• Subspeciality in Medical Oncology – Dr. Lutfi Kirdar Kartal Training and Research Hospital, Istanbul (2011)

• Breast cancer
• Colorectal cancer / colon cancer / rectal cancer
• Gastric (stomach) cancer
• Lymphoma
• Ovarian cancer
• Gastrointestinal stromal tumors (GIST)
• Advanced solid tumors requiring systemic therapy

• Chemotherapy cost in turkey
• Immunotherapy
• Chemotherapy
• Immunotherapy
• Targeted / smart drug therapy
• Hormone therapy
• Personalized cancer treatment planning
• Genetic-based treatment assessment
• Intraperitoneal oncologic treatments
• Cancer follow-up and systemic treatment management

• Member - Turkish Medical Oncology
• Member - Association European Society for Medical Oncology
• Member - Turkish Society of Internal Medicine
• Member - Turkish Medical Association